SUPERNUS PHARMACEUTICALS, INC. ($SUPN)
Filing Information
| Accession Number | 0001804567-26-000008 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
3,750
Total Value
$0.00
P&L
+inf% (+$179,100.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Tech. Ops. Officer | Performance Share Unit | Derivative | Feb 28, 2026 | Grant/Award | 3,750 | $0.00 | $0.00 | 3,750 | Direct | โ | View Details |